Uplizna
Uplizna
UPLIZNA is a prescription medicine used to treat adults with: Neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive; Immunoglobulin G4-related disease (IgG4-RD); Generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) or anti-muscle specific tyrosine kinase (MuSK) antibody positive.
Administration Information
UPLINZA is a twice-yearly treatment for NMOSD, IgG4-RD and gMG. The treatment is administered with 90-minute intravenous (IV) infusions twice a year (after initial two start-up doses 2 weeks apart).
Number of yearly treatments: 2
Potential Side Effects
- NMOSD: urinary tract infection and arthralgia.
- IgG4-RD: urinary tract infections and lymphopenia.
- gMG: headache and infusion-related reactions.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Uplizna website.
Helpful Resources
LEARN ABOUT NMOSD
LEARN ABOUT IgG4-RD
LEARN ABOUT gMG
HOW UPLINZA WORKS
UPLIZNA RESOURCES AND SUPPORT
SAGE TIPS ON MG
SAGE PATIENT STORY
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices, Patient Rights and Responsibilities, and Appointment Lateness and Cancelation are for reference only. Please contact us if you have any questions!
Patient Consent Form
HIPAA Privacy Authorization Form
Notice of Privacy Practices
Patient Rights and Responsibilities
Appointment Lateness and Cancelation
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP
Southwest Florida
Tampa Bay